Balchem Corporation

NasdaqGS BCPC

Balchem Corporation EBITDA for the Trailing 12 Months (TTM) ending September 30, 2024: USD 224.71 M

Balchem Corporation EBITDA is USD 224.71 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 7.69% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Balchem Corporation EBITDA for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 208.67 M, a 5.39% change year over year.
  • Balchem Corporation EBITDA for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 198.00 M, a 23.69% change year over year.
  • Balchem Corporation EBITDA for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 160.07 M, a 1.69% change year over year.
  • Balchem Corporation EBITDA for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 157.41 M, a 4.70% change year over year.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
Loading...
NasdaqGS: BCPC

Balchem Corporation

CEO Mr. Theodore L. Harris
IPO Date June 3, 1986
Location United States
Headquarters 52 Sunrise Park Road
Employees 1,300
Sector Materials
Industries
Description

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.

Similar companies

AXTA

Axalta Coating Systems Ltd.

USD 34.69

1.34%

KWR

Quaker Chemical Corporation

USD 132.16

2.36%

CBT

Cabot Corporation

USD 89.37

0.04%

ODC

Oil-Dri Corporation of America

USD 41.80

1.70%

SXT

Sensient Technologies Corporation

USD 69.55

1.92%

FUL

H.B. Fuller Company

USD 63.73

0.81%

MTX

Minerals Technologies Inc.

USD 75.62

2.83%

ASH

Ashland Inc.

USD 69.39

0.52%

IOSP

Innospec Inc.

USD 111.44

3.26%

StockViz Staff

January 15, 2025

Any question? Send us an email